Peter B. Gilbert

Also affiliated with Fred Hutch Cancer Center

Immunology and MicrobiologyMedicineMathematicsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 132 papers. Top paper: “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial”.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Scientific Reports(2021)10.1038/s41598-021-03154-6

N/A

3.8DataRank · unranked

80 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

CMV viral load kinetics as surrogate endpoints after allogeneic transplantation

Journal of Clinical Investigation(2020)10.1172/jci133960

N/A

2.4DataRank · unranked

55 citations

Brian D. Williamson, Bhavesh Borate, Jonathan L. Golob, Chiara Wychera, Terry Stevens‐Ayers +12 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Nature Communications(2023)10.1038/s41467-023-39292-w

N/A

1.9DataRank · unranked

44 citations

Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David C. Montefiori, Allyson Mateja +19 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Prospects for a safe COVID-19 vaccine

Science Translational Medicine(2020)10.1126/scitranslmed.abe0948

N/A

0.843DataRank · unranked

274 citations

Lawrence Corey, Prabhavathi Fernandes, Peter B. Gilbert, Peter J. Hotez, Srinivas Rao +5 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Nature Medicine(2022)10.1038/s41591-022-01953-6

N/A

0.731DataRank · unranked

130 citations

Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret +42 more

Nonparametric variable importance assessment using machine learning techniques

Biometrics(2020)10.1111/biom.13392

N/A

0.706DataRank · unranked

110 citations

Peter B. Gilbert, Marco Carone, Noah Simon, Brian D. Williamson

A General Framework for Inference on Algorithm-Agnostic Variable Importance

Journal of the American Statistical Association(2021)10.1080/01621459.2021.2003200

N/A

0.648DataRank · unranked

74 citations

Peter B. Gilbert, Noah Simon, Marco Carone, Brian D. Williamson

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

npj Vaccines(2023)10.1038/s41541-023-00630-0

N/A

0.557DataRank · unranked

40 citations

Youyi Fong, Holly Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule +37 more

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

Journal of Clinical Investigation(2023)10.1172/jci163338

N/A

0.553DataRank · unranked

14 citations

Andrew Fioré-Gartland, Stephen R. Walsh, Karina Yusim, Nicole Frahm, Marnie Elizaga +25 more

Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines

Clinical Infectious Diseases(2021)10.1093/cid/ciab226

N/A

0.524DataRank · unranked

32 citations

Donglin Zeng, Peter B. Gilbert, Dan-Yu Lin

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Inference for Treatment-Specific Survival Curves Using Machine Learning

Journal of the American Statistical Association(2023)10.1080/01621459.2023.2205060

N/A

0.477DataRank · unranked

23 citations

Alex Luedtke, Peter B. Gilbert, Marco Carone, Ted Westling

HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype

Cell Host & Microbe(2022)10.1016/j.chom.2022.06.005

N/A

0.470DataRank · unranked

22 citations

Andrew C. Hickey, Shida Shangguan, Philip K. Ehrenberg, Aviva Geretz, Lauryn Butler +21 more

Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial

Vaccine(2024)10.1016/j.vaccine.2024.02.071

N/A

0.457DataRank · unranked

20 citations

Youyi Fong, Nima S. Hejazi, Avi Kenny, Ying Huang, Marco Carone +3 more

Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

Scientific Reports(2022)10.1038/s41598-021-04376-4

N/A

0.449DataRank · unranked

19 citations

Pavitra Roychoudhury, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand, Thomas H. Payne +13 more

Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae689

N/A

0.444DataRank · unranked

8 citations

Xiaowei Wang, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Peter B. Gilbert +13 more

Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab342

N/A

0.430DataRank · unranked

6 citations

Brian D. Williamson, Zoe Moodie, Lindsay N. Carpp, Laurent Chambonneau, Carlos A. DiazGranados +2 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0.425DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01

JAIDS Journal of Acquired Immune Deficiency Syndromes(2020)10.1097/qai.0000000000002272

N/A

0.413DataRank · unranked

11 citations

Yuanyuan Zhang, Robert Bailer, Nicole Grunenberg, Lindsay N. Carpp, Kelly Seaton +7 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals

medRxiv(2024)10.1101/2024.03.15.24304305

N/A

0.375DataRank · unranked

7 citations

Wilton B. Williams, Stephen R. Walsh, Derek W. Cain, Matthew Clark, Ryan Tuck +38 more

Evaluating the Efficacy of COVID-19 Vaccines

medRxiv(2020)10.1101/2020.10.02.20205906

N/A

0.373DataRank · unranked

11 citations

Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, Peter B. Gilbert, Dan-Yu Lin

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance

Journal of Virology(2025)10.1128/jvi.01730-24

N/A

0.331DataRank · unranked

7 citations

Bronwen E. Lambson, Nonhlanhla N. Mkhize, Chivonne Moodley, Anna Yssel, Thandeka Moyo-Gwete +16 more

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Nature Communications(2023)10.1038/s41467-023-43399-5

N/A

0.330DataRank · unranked

8 citations

Lily Zhang, Shelly Karuna, Philip Andrew, Michal Juraska, Joshua A. Weiner +18 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Evaluation of treatment effect modification by biomarkers measured pre- and post-randomization in the presence of non-monotone missingness

Biostatistics(2020)10.1093/biostatistics/kxaa040

N/A

0.269DataRank · unranked

5 citations

Ying Huang, Peter B. Gilbert, Yingying Zhuang

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries

Transactions of the Royal Society of Tropical Medicine and Hygiene(2020)10.1093/trstmh/traa154

N/A

0.241DataRank · unranked

4 citations

Zoe Moodie, Michal Juraska, Youyi Fong, Lindsay N. Carpp, Laurent Chambonneau +5 more

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia

Vaccine(2022)10.1016/j.vaccine.2022.08.055

N/A

0.227DataRank · unranked

3 citations

Yanqing Sun, Michal Juraska, Zoe Moodie, Craig A. Magaret, Fei Heng +3 more

1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.2470

N/A

0.208DataRank · unranked

3 citations

Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +10 more

Data Fusion Using Weakly Aligned Sources

Journal of the American Statistical Association(2025)10.1080/01621459.2025.2476780

N/A

0.208DataRank · unranked

3 citations

Peter B. Gilbert, Rui Duan, Alex Luedtke, Sijia Li

A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development

Biostatistics(2024)10.1093/biostatistics/kxaf018

N/A

0.208DataRank · unranked

3 citations

James Peng, Larry Han, Theis Lange, Yun Lu, Lei Nie +10 more

Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption

The Annals of Applied Statistics(2022)10.1214/21-aoas1566

N/A

0.208DataRank · unranked

3 citations

Yingying Zhuang, Peter B. Gilbert, Ying Huang

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens

PLoS ONE(2024)10.1371/journal.pone.0310042

N/A

0.104DataRank · unranked

1 citations

Liana Wu, Yunda Huang, Aaron Hudson, Peter B. Gilbert, Brian D. Williamson

Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection

UNC Libraries(2022)10.17615/2a7e-y786

N/A

0.104DataRank · unranked

1 citations

Holly Janes, Peter B. Gilbert, Donglin Zeng, Yu Gu, Dan-Yu Lin

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Clinical Infectious Diseases(2025)10.1093/cid/ciaf558

N/A

0.104DataRank · unranked

1 citations

Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez +37 more

Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial

Statistics in Medicine(2025)10.1002/sim.10345

N/A

0.104DataRank · unranked

1 citations

Yanqing Sun, Li Li, Peter B. Gilbert, Fei Heng

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Estimation of conditional cumulative incidence functions under generalized semiparametric regression models with missing covariates, with application to analysis of biomarker correlates in vaccine trials

Canadian Journal of Statistics(2022)10.1002/cjs.11693

N/A

0.104DataRank · unranked

1 citations

Fei Heng, Unkyung Lee, Peter B. Gilbert, Yanqing Sun

Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Clinical Infectious Diseases(2021)10.1093/cid/ciab630

N/A

0DataRank · unranked

14 citations

Yu Gu, Donglin Zeng, Holly Janes, Peter B. Gilbert, Dan-Yu Lin

Super LeArner Prediction of NAb Panels (SLAPNAP): a containerized tool for predicting combination monoclonal broadly neutralizing antibody sensitivity

Bioinformatics(2021)10.1093/bioinformatics/btab398

N/A

0DataRank · unranked

25 citations

Craig A. Magaret, Peter B. Gilbert, Sohail Nizam, Courtney Simmons, David Benkeser +1 more

A controlled effects approach to assessing immune correlates of protection

Biostatistics(2022)10.1093/biostatistics/kxac024

N/A

0DataRank · unranked

18 citations

Youyi Fong, Avi Kenny, Marco Carone, Peter B. Gilbert

Nonparametric Estimation of the Causal Effect of a Stochastic Threshold-Based Intervention

Biometrics(2022)10.1111/biom.13690

N/A

0DataRank · unranked

16 citations

Wenbo Zhang, Peter B. Gilbert, Lars van der Laan

Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy

Scientific Reports(2022)10.1038/s41598-022-23342-2

N/A

0DataRank · unranked

14 citations

Terry P. Lybrand, Peter B. Gilbert, Thomas H. Payne, Chul‐Woo Pyo, Daniel E. Geraghty +2 more

Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021

Vaccine(2022)10.1016/j.vaccine.2022.05.016

N/A

0DataRank · unranked

13 citations

Richard Isbrucker, Nick Andrews, David Goldblatt, Paul T. Heath, Alane Izu +7 more

A controlled effects approach to assessing immune correlates of protection

Biostatistics(2022)10.1093/biostatistics/kxac24

N/A

0DataRank · unranked

10 citations

Youyi Fong, Avi Kenny, Marco Carone, Peter B. Gilbert

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.06.22.22276362

N/A

0DataRank · unranked

15 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Rapidly Identifying New Coronavirus Mutations of Potential Concern in the Omicron Variant Using an Unsupervised Learning Strategy

Research Square(2022)10.21203/rs.3.rs-1280819/v1

N/A

0DataRank · unranked

3 citations

Terry P. Lybrand, Peter B. Gilbert, Thomas H. Payne, Chul‐Woo Pyo, Daniel E. Geraghty +2 more

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Nature Communications(2023)10.1038/s41467-022-35768-3

N/A

0DataRank · unranked

102 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

PLoS Pathogens(2021)10.1371/journal.ppat.1009363

N/A

0DataRank · unranked

30 citations

Andrew Fioré-Gartland, Lamar M. Fleming, Lindsay N. Carpp, Anneta Naidoo, Michael S. Harper +13 more

A government-led effort to identify correlates of protection for COVID-19 vaccines

Nature Medicine(2021)10.1038/s41591-021-01484-6

N/A

0DataRank · unranked

37 citations

Rubén O. Donis, Peter B. Gilbert, Andrew W. Li, Najaf A. Shah, Christopher R. Houchens +1 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Evaluating Candidate Principal Surrogate Endpoints

UNC Libraries(2020)10.17615/sya7-f487

N/A

0DataRank · unranked

0 citations

Peter B. Gilbert, Michael G. Hudgens

Power to Detect the Effects of HIV Vaccination in Repeated Low‐Dose Challenge Experiments

UNC Libraries(2020)10.17615/c2p7-zm62

N/A

0DataRank · unranked

0 citations

Dan H. Barouch, John R. Mascola, Peter B. Gilbert, Chih‐Da Wu, Steven G. Self +1 more

Nonparametric Bounds and Sensitivity Analysis of Treatment Effects

UNC Libraries(2020)10.17615/ycca-t765

N/A

0DataRank · unranked

0 citations

Amy Richardson, Jason P. Fine, Michael G. Hudgens, Peter B. Gilbert

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments

UNC Libraries(2020)10.17615/p54e-td15

N/A

0DataRank · unranked

0 citations

Michael G. Hudgens, Peter B. Gilbert

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.09.012

N/A

0DataRank · unranked

14 citations

Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly Janes +8 more

Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials

UNC Libraries(2020)10.17615/dgkc-kf11

N/A

0DataRank · unranked

0 citations

Bryan E. Shepherd, Peter B. Gilbert, Michael G. Hudgens

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

iScience(2023)10.1016/j.isci.2023.107595

N/A

0DataRank · unranked

6 citations

Craig A. Magaret, Shelly Karuna, Lindsay N. Carpp, Huub C. Gelderblom, Yunda Huang +3 more

A Semiparametric Cox–Aalen Transformation Model with Censored Data

Biometrics(2023)10.1111/biom.13895

N/A

0DataRank · unranked

5 citations

Yinghao Pan, Yanqing Sun, Peter B. Gilbert, Xi Ning

Study design approaches for future active-controlled HIV prevention trials

Statistical Communications in Infectious Diseases(2023)10.1515/scid-2023-0002

N/A

0DataRank · unranked

7 citations

Sheila Kansiime, David V. Glidden, Alex Luedtke, Peter B. Gilbert, Fei Gao +2 more

Analysis of the Cox Model with Longitudinal Covariates with Measurement Errors and Partly Interval Censored Failure Times, with Application to an AIDS Clinical Trial

Statistics in Biosciences(2023)10.1007/s12561-023-09372-y

N/A

0DataRank · unranked

1 citations

Qingning Zhou, Peter B. Gilbert, Yanqing Sun

Semiparametric logistic regression for inference on relative vaccine efficacy in case-only studies with informative missingness

arXiv (Cornell University)(2023)10.48550/arxiv.2303.11462

N/A

0DataRank · unranked

1 citations

Peter B. Gilbert, Lars van der Laan

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy

medRxiv(2023)10.1101/2023.11.22.23298907

N/A

0DataRank · unranked

0 citations

Angela M. Early, Li Li, S. F. Schaffner, Marc Lievens, Akanksha Khorgade +27 more

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.14.571616

N/A

0DataRank · unranked

0 citations

Liana Wu, Yunda Huang, Aaron Hudson, Peter B. Gilbert, Brian D. Williamson

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Timing HIV infection with nonlinear viral dynamics

medRxiv(2020)10.1101/2020.08.13.20174243

N/A

0DataRank · unranked

0 citations

Morgane Rolland, Bethany L. Dearlove, Yifan Li, Merlin L. Robb, Joshua T. Schiffer +4 more

Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration

BMJ(2024)10.1136/bmj-2023-078525

N/A

0DataRank · unranked

28 citations

Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Jane Blazeby +31 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2308942121

N/A

0DataRank · unranked

21 citations

Hongjun Bai, Allan C. deCamp, Craig A. Magaret, Li Li, Kevin Gillespie +37 more

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

Rejoinder to “Nonparametric variable importance assessment using machine learning techniques”

Biometrics(2020)10.1111/biom.13389

N/A

0DataRank · unranked

2 citations

Peter B. Gilbert, Marco Carone, Noah Simon, Brian D. Williamson

Designing a Study of Correlates of Risk for Ebola Vaccination

American Journal of Epidemiology(2020)10.1093/aje/kwaa001

N/A

0DataRank · unranked

4 citations

Ira M. Longini, Peter B. Gilbert, M. Elizabeth Halloran

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection

mSphere(2020)10.1128/msphere.00738-19

N/A

0DataRank · unranked

9 citations

Nonhlanhla N. Mkhize, Michael T. Yin, Michael C. Keefer, David C. Montefiori, Georgia D. Tomaras +13 more

A Hybrid Approach for The Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy Trials

Journal of the Royal Statistical Society Series C (Applied Statistics)(2020)10.1111/rssc.12417

N/A

0DataRank · unranked

6 citations

Qi Li, Fei Heng, Peter B. Gilbert, Yanqing Sun

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Vaccines(2020)10.3390/vaccines8040741

N/A

0DataRank · unranked

27 citations

Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang +21 more

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

Viruses(2024)10.3390/v16091365

N/A

0DataRank · unranked

2 citations

S. Munir Alam, Erica Andersen‐Nissen, Lindsay N. Carpp, One Dintwe, Britta Flach +12 more

RV144 HIV-1 vaccination impacts post-infection antibody responses

PLoS Pathogens(2020)10.1371/journal.ppat.1009101

N/A

0DataRank · unranked

33 citations

Ningbo Jian, Bonnie M. Slike, Dominic Paquin‐Proulx, Gina Donofrio, Aljawharah Alrubayyi +31 more

On the Role of Surrogates in Conformal Inference of Individual Causal Effects

arXiv (Cornell University)(2024)10.48550/arxiv.2412.12365

N/A

0DataRank · unranked

1 citations

Peter B. Gilbert, Larry Han, Chenyin Gao

A Surrogate Endpoint Based Provisional Approval Causal Roadmap

arXiv (Cornell University)(2024)10.48550/arxiv.2407.06350

N/A

0DataRank · unranked

0 citations

James Peng, Larry Han, Theis Lange, Yun Lu, Lei Nie +10 more

Addressing Confounding and Continuous Exposure Measurement Error Using Corrected Score Functions

arXiv (Cornell University)(2024)10.48550/arxiv.2407.09443

N/A

0DataRank · unranked

0 citations

Bryan S. Blette, Peter B. Gilbert, Michael G. Hudgens, Brian Richardson

GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies

PLoS Computational Biology(2024)10.1371/journal.pcbi.1012581

N/A

0DataRank · unranked

0 citations

Rachel L. Spreng, Kelly E. Seaton, S. Moses Dennison, Lindsay C. Dahora, Daniel J. Schuster +8 more

A class of nonparametric methods for evaluating the effect of continuous\n treatments on survival outcomes

arXiv (Cornell University)(2024)10.48550/arxiv.2412.09786

N/A

0DataRank · unranked

0 citations

Peter B. Gilbert, Aaron Hudson, Yutong Jin

Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial

Journal of Causal Inference(2020)10.1515/jci-2019-0022

N/A

0DataRank · unranked

9 citations

Bryan S. Blette, Bryan E. Shepherd, Michael G. Hudgens, Peter B. Gilbert

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates

Statistics in Biosciences(2020)10.1007/s12561-020-09266-3

N/A

0DataRank · unranked

8 citations

Yuanyuan Zhang, Zong Zhang, Peter B. Gilbert, Yunda Huang

Regression analysis of semiparametric Cox-Aalen transformation models with partly interval-censored data

Electronic Journal of Statistics(2025)10.1214/24-ejs2341

N/A

0DataRank · unranked

2 citations

Yanqing Sun, Yinghao Pan, Peter B. Gilbert, Xi Ning

Addressing confounding and continuous exposure measurement error using corrected score functions

Biometrics(2025)10.1093/biomtc/ujaf045

N/A

0DataRank · unranked

1 citations

Bryan S. Blette, Peter B. Gilbert, Michael G. Hudgens, Brian E. Richardson

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2025)10.17615/t225-p023

N/A

0DataRank · unranked

0 citations

Hong Zhao, Lennie Chen, Li Li, Wenjie Deng, Tanmoy Bhattacharya +37 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial

Vaccine(2025)10.1016/j.vaccine.2025.127718

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Bo Zhang, Nadine Rouphael, Angela R Branche, Thomas Martin +13 more

Immune Correlates and Vaccine Immunobridging: Statistical Innovations, Challenges, and Opportunities

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf451

N/A

0DataRank · unranked

0 citations

Charles J. Wolock, Antonio Olivas‐Martínez, Andrea Rotnitzky, Peter B. Gilbert, Marco Carone

Inference on Variable Importance for Treatment Effect Heterogeneity: Shapley Values and Beyond

ArXiv.org(2025)10.48550/arxiv.2510.18843

N/A

0DataRank · unranked

0 citations

Peter B. Gilbert, Alex Luedtke, Paweł Morzywołek

Generalized nonparametric temporal modeling of recurrent events with application to a malaria vaccine trial

Biometrics(2025)10.1093/biomtc/ujaf146

N/A

0DataRank · unranked

0 citations

Yanqing Sun, Jing Xu, Peter B. Gilbert, Fei Heng

A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf572

N/A

0DataRank · unranked

0 citations

Lauren Dang, Eric Chun‐Pu Chu, Jonathan Fintzi, Holly Janes, Peter B. Gilbert +13 more

Sequentially Doubly Robust Estimation of Conditional Survival Probability with Time-Varying Covariates

ArXiv.org(2025)10.48550/arxiv.2510.10372

N/A

0DataRank · unranked

0 citations

Marco Carone, Alex Luedtke, Peter B. Gilbert, Hongxiang Qiu

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Research Square(2021)10.21203/rs.3.rs-862572/v1

N/A

0DataRank · unranked

10 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1863

N/A

0DataRank · unranked

19 citations

Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, Peter B. Gilbert, Dan-Yu Lin

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.15.448495

N/A

0DataRank · unranked

8 citations

Terry P. Lybrand, Peter B. Gilbert, Thomas R. Hawn, Joshua T. Schiffer, Leonidas Stamatatos +5 more

Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection

medRxiv(2021)10.1101/2021.04.16.21255614

N/A

0DataRank · unranked

2 citations

Yu Gu, Donglin Zeng, Holly Janes, Peter B. Gilbert, Dan-Yu Lin

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

medRxiv(2021)10.1101/2021.09.09.21263049

N/A

0DataRank · unranked

2 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Variants in nucleocapsid protein and endoRNase are found to associate with severe COVID-19 in a case-control study in Washington State, USA

Research Square(2021)10.21203/rs.3.rs-888049/v1

N/A

0DataRank · unranked

0 citations

Pavitra Roychoudhury, Keith R. Jerome, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand +13 more

Variants in nucleocapsid protein and endoRNase are found to associate with severe COVID-19 in a case-control study in Washington State, USA

Research Square(2021)10.21203/rs.3.rs-888049/v2

N/A

0DataRank · unranked

0 citations

Pavitra Roychoudhury, Keith R. Jerome, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand +13 more

Evaluating the Long-Term Efficacy of COVID-19 Vaccines

medRxiv(2021)10.1101/2021.01.13.21249779

N/A

0DataRank · unranked

15 citations

Donglin Zeng, Peter B. Gilbert, Dan-Yu Lin

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

UNC Libraries(2021)10.17615/pr2z-dq66

N/A

0DataRank · unranked

3 citations

Jesus F. Salazar-Gonzalez, Tongye Shen, Craig A. Magaret, William R. Schief, Brian Gaschen +27 more

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj Vaccines(2021)10.1038/s41541-021-00305-8

N/A

0DataRank · unranked

15 citations

Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall +25 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

Viruses(2021)10.3390/v13101921

N/A

0DataRank · unranked

19 citations

Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth M. Krantz, Elizabeth R. Brown +10 more